While lots of states have granted authorization for clinical marijuana utilization, it continues to be classified as being a Routine one drug under federal criteria, lacking identified healthcare programs and posing a major possibility of abuse. On top of that, According to the American Society of Medical Oncology's 2017 recommendations, there